
Latest Science News
Isomorphic Labs Delays AI Drug Discovery Clinical Trials
Google-backed Isomorphic Labs, using AI for drug discovery, now expects first clinical trials by end of 2026, as stated by CEO Demis Hassabis. This delay highlights challenges in translating AI models to human trials.
The update was shared on January 22, 2026.
OU Team Advances Drone Tech for Weather Forecasting
University of Oklahoma's 3D Mesonet project tests drones to gather spatiotemporal atmospheric data, improving predictions for thunderstorms and severe weather. This aims to enhance short-term, high-impact weather forecasts across the US.
Details reported January 22, 2026.
Cancer Vaccine Shows Promise for Lynch Syndrome Prevention
MD Anderson's Phase Ib/II trial of NOUS-209 vaccine offers early evidence for preventing cancer in high-risk Lynch syndrome patients. Led by Eduardo Vilar-Sanchez, it suggests immune-based interception before cancer develops.
Results shared January 22, 2026.
Novel Immunotherapy Overcomes Cancer Treatment Resistance
Phase I trial of linavonkibart (SRK-181) targets TGF-beta1, overcoming resistance to anti-PD-1 therapies in multiple cancers. Led by Timothy Yap at MD Anderson, it shows potential after prior failures.
Published in Nature Medicine, announced January 22, 2026.
Ancient Nitrogenase Enzyme Resurrected Explains Early Life
USU biochemists reconstructed 3.2-billion-year-old nitrogenases, revealing nitrogen fixation evolution key to life's origins. NASA-funded MUSE project aids understanding of early Earth and space agriculture.
Published in Nature Communications January 22, 2026.
ATLAS Confirms Radial Expansion in Quark-Gluon Plasma
LHC's ATLAS experiment shows collective radial flow in lead ion collisions, confirming fluid nature of quark soup hotter than sun's core. Supports RHIC discoveries, with ALICE corroboration in Physical Review Letters.
Brookhaven Lab analysis advances Big Bang matter insights.